Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit - Reykjavik, Iceland, July 2021 [0.03%]
2021年7月“新冠疫苗高接种率的美国海军游轮抵达雷克雅未克后发生新冠肺炎聚集性疫情”现场报告
Tammy E Servies,Eric C Larsen,Rodney C Lindsay et al.
Tammy E Servies et al.
Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention - New York City, November-December 2021 [0.03%]
纽约市2021年11月至12月一起与大型室内会议相关的SARS-CoV-2传播事件调查报告
Samira Sami,Libby Horter,Diana Valencia et al.
Samira Sami et al.
During November 19-21, 2021, an indoor convention (event) in New York City (NYC), was attended by approximately 53,000 persons from 52 U.S. jurisdictions and 30 foreign countries. In-person registration for the event began on November 18, 2...
Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021 [0.03%]
2021年11月18日—12月20日期间参加一次会议的社交网络人群中发生的SARS-CoV-2 B.1.1.529（奥密克戎）变异株感染多州暴发疫情——纽约市
Sarah E Smith-Jeffcoat,Mary A Pomeroy,Sadia Sleweon et al.
Sarah E Smith-Jeffcoat et al.
On December 2, 2021, the Minnesota Department of Health (MDH) notified CDC of a COVID-19 case caused by sequence-confirmed SARS-CoV-2 B.1.1.529 (Omicron) variant in a Minnesota resident (patient A), the first such case identified in the sta...
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022 [0.03%]
2021年7月至2022年1月14个州的儿童和青少年实验室确诊COVID-19住院病例—COVID-NET
Kristin J Marks,Michael Whitaker,Onika Anglin et al.
Kristin J Marks et al.
The first U.S. case of COVID-19 attributed to the Omicron variant of SARS-CoV-2 (the virus that causes COVID-19) was reported on December 1, 2021 (1), and by the week ending December 25, 2021, Omicron was the predominant circulating variant...
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022 [0.03%]
孕期接种mRNA新冠疫苗对预防婴儿因新冠肺炎住院的有效性
Natasha B Halasa,Samantha M Olson,Mary A Staat et al.
Natasha B Halasa et al.
COVID-19 vaccination is recommended for persons who are pregnant, breastfeeding, trying to get pregnant now, or who might become pregnant in the future, to protect them from COVID-19.§ Infants are at risk for life-threatening complications...
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection - California, February-December 2021 [0.03%]
关于口罩或呼吸器在室内公共场所使用对预防SARS-CoV-2感染有效性的评估——加州，2021年2月—12月
Kristin L Andrejko,Jake M Pry,Jennifer F Myers et al.
Kristin L Andrejko et al.
The use of face masks or respirators (N95/KN95) is recommended to reduce transmission of SARS-CoV-2, the virus that causes COVID-19 (1). Well-fitting face masks and respirators effectively filter virus-sized particles in laboratory conditio...
Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020 [0.03%]
2012-2020年全球麻疹腮腺炎风疹疫苗接种及先天性风疹综合征防控进展报告
Laura A Zimmerman,Jennifer K Knapp,Sébastien Antoni et al.
Laura A Zimmerman et al.
Rubella virus is a leading cause of vaccine-preventable birth defects and can cause epidemics. Although rubella virus infection usually produces a mild febrile rash illness in children and adults, infection during pregnancy, especially duri...
Preventive Dental Care and Oral Health of Children and Adolescents With and Without Heart Conditions - United States, 2016-2019 [0.03%]
美国2016-2019年具有和不具有心脏疾病的儿童及青少年的口腔保健与口腔健康
Karrie F Downing,Lorena Espinoza,Matthew E Oster et al.
Karrie F Downing et al.
Approximately 900,000 U.S. children have heart conditions, such as congenital heart disease (1). These children might be at increased risk for life-threatening infective endocarditis from oral bacteria in the bloodstream (2). Therefore, pre...
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022 [0.03%]
2021年7月15日至9月23日和2021年12月21日至2022年1月27日期间感染B.1.617.2（德尔塔）和B.1.1.529（奥密克戎）变异株成人住院患者的临床特征及结局——加利福尼亚州一家医院的一项研究
Matthew E Modes,Michael P Directo,Michael Melgar et al.
Matthew E Modes et al.
In mid-December 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, surpassed the B.1.617.2 (Delta) variant as the predominant strain in California.§ Initial reports suggest that the Omicron variant is more...